These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15917502)

  • 1. Attitudes and practices regarding the use of methadone in US state and federal prisons.
    Rich JD; Boutwell AE; Shield DC; Key RG; McKenzie M; Clarke JG; Friedmann PD
    J Urban Health; 2005 Sep; 82(3):411-9. PubMed ID: 15917502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.
    Nunn A; Zaller N; Dickman S; Trimbur C; Nijhawan A; Rich JD
    Drug Alcohol Depend; 2009 Nov; 105(1-2):83-8. PubMed ID: 19625142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
    Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
    Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification.
    Sheard L; Wright NM; Adams CE; Bound N; Rushforth B; Hart R; Tompkins CN
    Trials; 2009 Jul; 10():53. PubMed ID: 19602218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-Based Methadone Maintenance in a Large Detention Center is Associated with Decreases in Inmate Recidivism.
    Westerberg VS; McCrady BS; Owens M; Guerin P
    J Subst Abuse Treat; 2016 Nov; 70():1-6. PubMed ID: 27692182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
    Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
    Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
    Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
    Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
    Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
    Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
    Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of opioid maintenance programs for treating drug dependence in prisons.
    Roselló-Jordá S; Espinós-Navarro C; Molés-Julio MP
    Rev Esp Sanid Penit; 2023; 25(3):112-121. PubMed ID: 38289166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.
    Ahmad A; Bromberg DJ; Shrestha R; Salleh NM; Bazazi AR; Kamarulzaman A; Shenoi S; Altice FL
    Int J Drug Policy; 2024 Apr; 126():104369. PubMed ID: 38484531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising opioid substitution therapy in the prison environment.
    Alam F; Wright N; Roberts P; Dhadley S; Townley J; Webster R
    Int J Prison Health; 2019 Dec; 15(4):293-307. PubMed ID: 31532339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.
    Moore KE; Oberleitner L; Smith KMZ; Maurer K; McKee SA
    J Addict Med; 2018; 12(2):156-162. PubMed ID: 29341974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder.
    Peeler M; Fiscella K; Terplan M; Sufrin C
    J Correct Health Care; 2019 Jan; 25(1):4-14. PubMed ID: 30616487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
    Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program.
    McKenzie M; Macalino G; McClung C; Shield DC; Rich JD
    J Opioid Manag; 2005; 1(3):147-51. PubMed ID: 17315418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage with methadone treatment upon release from incarceration: a promising opportunity.
    Rich JD; McKenzie M; Shield DC; Wolf FA; Key RG; Poshkus M; Clarke J
    J Addict Dis; 2005; 24(3):49-59. PubMed ID: 16186082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial Management of Incarcerated Pregnant Women With Opioid Use Disorder.
    O'Connor A; Bowling N
    J Correct Health Care; 2020 Jan; 26(1):17-26. PubMed ID: 31960750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
    Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
    Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.